Marcel Bally

Marcel Bally has a diverse work experience in the field of biomedicine and pharmaceuticals. Marcel is currently serving as the Theme 1 Leader at NanoMedicines Innovation Network since March 2019. Previously, they held the position of Chief Scientific Officer at Cuprous Pharmaceuticals Inc. from December 2016, where they were responsible for leading the development of Metaplex, a technology platform for creating new nanomedicines. Prior to that, they worked at BC Cancer as the Head of the Department of Experimental Therapeutics since January 1991.

From 1980 to 1985, Marcel Bally attended The University of British Columbia. However, there is no information provided regarding their degree or field of study during this period.